Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMBC Capital Holdings Limited, often referred to by its abbreviation CMBCC, is a Hong Kong-based financial services company and a subsidiary of China Merchants Bank. While primarily an investment firm, the company is a significant player in the healthcare sector through its specialized investment vehicles, such as the CMBCC Co-High Medical Investment Fund. The firm focuses on financing and providing capital to high-growth medical and pharmaceutical enterprises, particularly those seeking listing under Chapter 18A of the Hong Kong Stock Exchange. Its services include asset management, corporate finance advisory, and direct investment in the life sciences and biotechnology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMBCC.